Evicenter
MarkdownMedical informationP&T meetings
Lonimecgene renparvovec (TSHA-102)

Rett syndrome

Launch
Not announced
Last updated
199 sources

Product information and disease descriptionPlace of product in therapyDisease descriptionBurden of Rett syndrome

Economic burden and healthcare resource utilization

13 evidence topics · 12 sources

US claims, 5,940 females: all-cause and Rett-related healthcare resource utilization
US claims, 5,940 females: all-cause and Rett-related healthcare costs

“Mean all-cause healthcare costs were $40,326 per-patient-per-year, with medical costs driven by home/hospice care visits, therapeutic services, outpatient visits, and inpatient visits.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote

“RTT-related healthcare costs comprised 45% of all-cause healthcare costs.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote

“During the observation period, female patients with RTT incurred mean all-cause total healthcare costs of $34,772 (86%) in pre-adjudicated medical costs and $5,554 (14%) in adjudicated pharmacy costs (Table 7).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote

“Mean all-cause medical costs were primarily driven by home/hospice care visits ($12,054), followed by therapeutic services ($7,071), OP visits ($6,791), and inpatient visits ($6,088) among the overall cohort.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote

“Mean RTT-related total healthcare costs PPPY included $14,643 in pre-adjudicated medical costs and $3,428 in adjudicated pharmacy costs (Table 7).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote

“All costs were inflation-adjusted to 2021 US dollars (USD).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote